抗蠕蟲藥
由寄生人體的蠕蟲感染所致的疾病稱為蠕蟲病。這些蠕蟲主要包括絳蟲、線蟲和吸蟲。據世界衛生組織（WHO）估計，全球約有近20億人口受到蠕蟲感染的影響，這嚴重威脅著人類的健康和社會經濟的發展。
近年來，開發出了許多廣譜、高效且安全的抗蠕蟲藥物，例如阿苯達唑和甲苯達唑，這些新藥已經取代了傳統的山道年和己雷瑣辛等。吡喹酮對血吸蟲病的治愈率可達90%以上，而乙胺嗪則是治療絲蟲病的有效藥物。
| 中文名稱 | 英文名稱 | CAS號 | 化學式 |
|---|---|---|---|
| 阿苯達唑亞砜 | 4-(methylsulfonylamino)phenol | 51767-39-6 | C7H9NO3S |
| 阿苯達唑亞砜 | ricobendazole | 54029-12-8 | C12H15N3O3S |
| 芬苯達唑 | fenbendazole | 43210-67-9 | C15H13N3O2S |
| 氫溴酸檳榔堿 | arecoline hydrobromide | 300-08-3 | BrH*C8H13NO2 |
| 安絲菌素 P 3 | ansamitocin P-3 | 66584-72-3 | C32H43ClN2O9 |
| 多拉菌素 | doramectin | 117704-25-3 | C50H74O14 |
| —— | Dectomax | 117704-25-3 | C50H74O14 |
| —— | (1'R,2R,3S,4'S,6S,8'R,10'E,13'S,14'E,16'E,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
| —— | Pharmakon1600-01505902 | 117704-25-3 | C50H74O14 |
| —— | (1'R,2R,3S,4'S,6S,8'R,12'S,13'S,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
| —— | (1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-[(2S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
| —— | 3-O-De[2-(acetylmethylamino)-1-oxopropyl]-3-O-(1-oxobutyl)maytansine | 66584-72-3 | C32H43ClN2O9 |
| —— | Doramectin synthetic | 117704-25-3 | C50H74O14 |
| —— | Maytansine, 2'-de(acetylmethylamino)-2'-methyl- | 66584-72-3 | C32H43ClN2O9 |
| —— | (1'R,2R,3S,4'S,6S,8'R,10'Z,12'S,14'Z,16'Z,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | 117704-25-3 | C50H74O14 |
| —— | ansamitocin P-3 | 66584-72-3 | C32H43ClN2O9 |
| —— | Epi-doramectin | 117704-25-3 | C50H74O14 |
| —— | Ansamitocin P 3 | 66584-72-3 | C32H43ClN2O9 |
聯系我們
關注我們
公眾號
